is part of the Global Exhibitions Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Accreditation is the official process of recognising an establishment as having the status and the qualifications to perform a particular activity. It gives you an independent assurance that your business is capable of delivering outstanding patient care. It also ensures that your standards for quality are maintained and will continue to improve regardless of changes in personnel.
According to recent reports, the European medical laboratory market is expected to reach U.S. $15.5 billion by 2024 and the laboratory market industry is projected to show annual growth rates averaging approximately two per cent for laboratory services up to 2020. This assessment is based on analyses for countries such as Germany, France, Italy, Spain, Switzerland, Sweden, Norway and Portugal, which show that the European laboratory market trends display a constant growth.
Point of Care Tests (POCT) refers to rapid diagnostic tests performed at or near the consultation of patients to make early decisions about patient management; but this definition continues to evolve. These tests are typically easy to perform and interpret by trained users. POCTs are widely used in the provision of healthcare services in a variety of settings such as general practitioner clinics, hospital clinics and wards, emergency departments, pharmacies etc. Nowadays, some tests can even be performed in the comfort of a patient’s own home.
Medical laboratories, whether in hospitals or in freestanding locations, have complex operations and procedures that require physical contact with patient samples and reagents.
Over a decade ago, predictions were made about the rapid growth of data on the World Wide Web, and the ability to gain meaningful insight from this information.
Only a few years ago the term digital pathology implied a static snapshot obtained from a digital camera mounted on a conventional microscope, and telepathology implied remotely viewing a microscope slide via an analogue camera.
Moving towards consolidation, standardisation and automation in the laboratory to tackle today’s challenges and tomorrow’s complex healthcare landscape.
Autoantibody determination plays an important role in the diagnosis and differentiation of autoimmune bullous dermatoses (AIBD). Various autoantibodies against skin structures can be detected by serological methods such as indirect immunofluorescence (IIF) and ELISA.
Arboviruses, or arthropod-borne viruses, are on the march globally. Increased urbanisation and international travel facilitate the spread of mosquito vectors and hence the viral diseases they carry.
Sexually transmitted infections (STIs) are a major and growing health problem in all parts of the world. According to the World Health Organisation (WHO) more than one million STIs are acquired worldwide every day. Untreated, they can lead to serious long-term sequelae, especially infertility.
Advances in medicine in the 17th century provided the foundation for diagnostic laboratory testing. The discovery of the circulation of blood by William Harvey and subsequent development of procedures to withdraw blood from a patient's vein for therapeutic purposes have enabled physicians to utilise blood to detect and monitor disease.
Prader-Willi syndrome (PWS) and Angelman syndrome (AS) are distinct genetic disorders caused by lack of expression of paternally (PWS) or maternally (AS) imprinted genes in the 15q11–15q13 region, which is known as the Prader-Willi/Angelman syndrome critical region (PWASCR).
Since the announcement of the first working draft of the Human Genome on June 26, 2000, then President of the United States, Mr Bill Clinton had declared, “Genome Science will have a real impact on our lives - and even more, on the lives of our children.
To find out more about MEDLAB and how you can be involved, get in touch with:
+971 (0) 4 336 7334